Prolactin, growth hormone, and IGF-1 in ankles and plasma of adjuvant arthritic rats

References

• Berczi I, Nagy E. Possible role of prolactin in adjuvant arthritis. Arthritis Rheum 1982;25:591.
   PubMedGoogle Scholar
• Nagy E, Friesen HG, Sehon AH, Berczi I. Immuno-modulation in rats by transplantable anterior pituitary tumors. Endocrinology 1985;116:1117.
   PubMedGoogle Scholar
• Fernandez-Ruiz JJ, Ubeda E, Cebeira M, Agrasal C, Treguerres JAF, Ramos JA, et al. Modification of plasma protein level and catecholamine content in an ectopic pituitary gland transplanted under the kidney capsule. Horm Res 1987;25:105.
   Google Scholar
• Neidhart M, Fluckiger EW. Hyperprolactinaemia in hypo-physectomized or intact male rats and the development of adjuvant arthritis. Immunology 1992;77:449–55.
   PubMed Web of Science ®Google Scholar
• Edwards III CK, Schepper JM, Yunger LM, Kelley KW. Somatotropin and prolactin enhance respiratory burst activity of macrophages. Ann N Y Acad Sci 1988;540:698.
   PubMedGoogle Scholar
• Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci USA 1986;83:2599.
   Google Scholar
• Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypo-prolactinemic mice. Science 1988;239:401.
   Google Scholar
• Mukheijee P, Mastro AM, Hyper WC. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocri-nology 1990;126: 88–94.
   Google Scholar
• Davies UM, Rooney M, Preece MA, Ansell BM, Woo P. Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone. J Rheumatol 1994;21:153–8.
   Google Scholar
• Bernstein BH, Stobei D, Singsen BH, Koster-King K, Kornreich HK, Hanson V. Growth retardation in juvenile rheumatoid arthritis (JRA). Arthritis Rheum 1977;Suppl 20:212–6.
   Google Scholar
• Davies UM, Jones J, Reeve J, Camacho-Hubner C, Charlett A, Ansell BM, et al. Juvenile rheumatoid arthritis. Effect of disease activity and recombinant human growth factor 1, insulin-like growth factor binding protein 1 and 3, and osteocalcin. Arthritis Rheum 1997;40: 332–40.
   Google Scholar
• Isaakson OGP, Jansson JO, Gause AM. Growth hormone stimulate long bone growth directly. Science 1982;216:1237–9.
   Google Scholar
• D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentra-tions of somatomedin C: further evidence of multiple sites of synthesis and paracrine autocrine mechanisms of action. Proc Natl Acad Sci USA 1984;81:936–9.
   Google Scholar
• Dore S, Abribat T, Rousseau N, Brazeau P, Tardif G, Dibattista JA, et al. Increased insulin-like growth factor 1 production by human osteoarthritic chondrocytes is not dependent on growth hormone action. Arthritis Rheum 1995;38:413–9.
   PubMed Web of Science ®Google Scholar
• Isgaard J, Moller C, Isaksson OGP, Nilsson A, Matheus LS, Norstedt G. Regulation of insulin-like growth factor messen-ger ribonucleic acid in rat growth plate by growth hormone. Endocrinology 1988;122:1515–20.
   PubMed Web of Science ®Google Scholar
• Keyszer GM, Heer AH, Kriegsmann J, Geiler T, Keysser C, Gay RE, et al. Detection of insulin-like growth factor 1 and 11 in synovial tissue specimens of patients with rheumatoid arthritis and osteoarthritis by in situ hybridization. J Rheumatol 1995;22:275–81.
   PubMedGoogle Scholar
• Pearson CM, Wood FD. Study of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum 1959;2:440–59.
   Google Scholar
• Ahmed M, Bjurholm A, Srinivasan GR, Theodorsson E, Kreicberg A. Extraction of neuropeptides from joint tissue for quantitation by radioimmunoassay. A study in the rat. Peptides 1994;15:317–22.
   Google Scholar
• Lowly OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem 1951;264:265–75.
   Google Scholar
• Calvino B, Besson J-M, Mounier F, Kordon C, Bluet-Pajot M-T. Chronic pain induces a paradoxical increase in growth hormone secretion without affecting other hormones related to acute stress in the rat. Pain 1992;49:27–32.
   Google Scholar
• Neidhart M. Prolactin in autoimmune diseases (44251). Minireview, Pro Society Expt Biol Med 1998;217:408–19.
   PubMedGoogle Scholar
• Sabharwal P, Glaser R, Lafuse W, Varma S, Liu Q, Arkins S, et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: An autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 1992;89: 7713–6.
   PubMed Web of Science ®Google Scholar
• Pellgrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Cell Endocrinol 1992;6:1023–31.
   Google Scholar
• O'Neal KD, Montgomery DW, Truong TM, Yu-Lee LY. Prolactin gene expression in human thymocytes. Mol Cell Endocrinol 1992;87:R19–R23.
   Google Scholar
• Richard RG, Hartman SM. Human dermal fibroblast cells express Prolactin in vitro. J Invest Dermatol 1996;106:1250–5.
   PubMedGoogle Scholar
• Lavalle C. Prolactin- A hormone with immunoregulatory properties that leads to new therapeutic approaches in rheumatic diseases. J Rheumatol 1992;19:839–41.
   PubMedGoogle Scholar
• Reinhardt WO, Li CH. Experimental production of arthritis in rats by hypophyseal growth hormone. Science 1953;117: 295–7.
   PubMed Web of Science ®Google Scholar
• Fioravanti A, Govoni M, La Montagna G, Perpignano G, Tirri G, Trotta F, et al. Somatostatin 14 and joint inflammation: Evidence for intraarticular efficiency of pro-longed administration in rheumatoid arthritis. Drugs Exp Clin Res 1995;XXI (3):97–103.
   Google Scholar
• Matucci-Cerinic M, Borrelli F, Generini S, Cantelmo A, Marcucci I, Martelli F, et al. Somatostatin-induced modula-tion of inflammation in experimental arthritis. Arthritis Rheum 1995;38:1687–93.
   PubMed Web of Science ®Google Scholar
• Denko CW, Boja B, Moskowitz RW. Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. J Rheumatol 1990;17: 1217–21.
   Google Scholar
• Kato Y, Chihara K, Ohgo S, Twasaki Y, Abe H, Imura H. Growth hormone and prolactin release by substance P in rats. Life Sci 1976;i9:441–6.
   Google Scholar
• Rivier C, Brown M, Vale W. Effect of neurotensin, substance P and morphine sulphate on the secretion of prolactin and growth hormone in the rat. Endocrinology 1977;100:751–4.
   Google Scholar
• Calvino B, Maillet S, Pradelles P, Besson JM, Couraud JY. Levels of substance P-like immunoreactivity in plasma and cerebrospinal fluid during the course of Freud adjuvant-induced arthritis: a chronic pain model, CR Acad Sci (Paris) 1991;312:427–32.
   Google Scholar
• Ahmed M, Bjurholm A, Theodorsson E, Schultzberg M, Kreicberg A. Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. A combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum 1995;38 (5):699–709.
   Google Scholar
• Elhassan AM, Lindgren JU, Hultenby K, Adem A. Neurokinin-A in bone and joint tissues: Changes in adjuvant arthritis. J Bone Miner Res 1999;14:73–9.
   PubMedGoogle Scholar
• Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. Release of multiple hormones by direct action of interleukin-1 on pituitary cells. Science 1987;238: 519–21.
   Google Scholar
• Rettori V, Jurcovicova J, McCann SM. Central action of interleukin-1 in altering the release of TSH, growth hormone, and prolactin in the male rat. J Neurosci Res 1987;18: 179–83.
   Google Scholar
• Beach JE, Smallridge RC, Kinzer CA, Bernton EW, Holaday JW, Fein HG. Rapid release of multiple hormones from rat pituitaries perfused with recombinant interleukin-1. Life Sci 1989;44:1 —7.
   PubMedGoogle Scholar
• Fernihough JK, Billingham ME, Cwyfan-Hughes S, Holly JM. Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum 1996;39:1556–65.
   PubMed Web of Science ®Google Scholar
• Verschure PJ, Van Marie J, Joosten LA, Van Den Berg WB. Histochemical analysis of insulin-like growth factor-1 binding sites in mouse normal and experimentally induced arthritic articular cartilage. Histochem J 1996;28:13–23.
   PubMedGoogle Scholar
• Mohan S. Insulin-like growth factor binding proteins in bone and cell regulation. Growth Regul 1993;3:67–70.
   PubMedGoogle Scholar
• Mohan S, Baylink DJ. Insulin-like growth factor system components and the coupling of bone formation to resorp-tion. Horm Res 1996;45 Suppl 1:59–62.
   PubMedGoogle Scholar
• Matsumoto T, Gargosky SE, Iwasaki K, Rosenfeld RG. Identification and characterization of insulin-like growth factors (IGFs), insulin-like growth factor binding protein (IGFBPs) and IGFBPs proteases in human synovial fluid. J Clin Endocrinol Metab 1996;81:150–5.
   PubMed Web of Science ®Google Scholar
• Isaksson OGP, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987;8:426 —38.
   PubMedGoogle Scholar
• Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RG. An interleukin-1 like factor stimulates bone resorption in vitro. Nature1983;306: 378— 80.
   Google Scholar
• Saklatavala J, Sarsfield SJ, Townsed Y. Pig interleukin-1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation and fever. J Exp Med 1985;162: 1208–15.
   Google Scholar